story & management
Back in 2011, Prof. Matti Nykter, the head of a bioinformatics group in Finland, had been collaborating for years with a broad spectrum of life science research groups. More and more scientists had recognized the value of creating and validating their hypotheses using microarray and sequencing experiments. With ever more accessible omics experiments, but scarce bioinformatics professionals, research groups struggled to understand their data. Prof. Nykter realized that most of these scientists would actually benefit more from working with a bioinformatics contract research organization (CRO) rather than relying on scientific collaboration alone, and decided to found a commercial bioinformatics contract research organization (CRO) to set a new standard in providing bioinformatics support to scientists.
A new way of doing bioinformatics
A bioinformatics contract research organization (CRO) combines the best aspects of academic collaboration, hiring a bioinformatician and using the services of a company.
We set out to create a new model for the way that life science researchers can access bioinformatics resources. Much like what commercial and core sequencing service providers have done for access to omics experiments, we strive to offer the same level of service with data analysis. In order to sequence their samples, teams do not need to buy a sequencing instrument first. When it comes to analyzing data, hiring people or collaborating should not be a necessary requirement either. We set out to develop a bioinformatics contract research organization (CRO) model that would surpass collaboration, recruitment and commercial software in speed, quality and cost-effectiveness.
The key element in our projects is that we assemble an optimal team of professionals to integrate into our clients’ teams, and leverage our bioinformatics infrastructure to deliver the greatest impact in the least amount of time. The effectiveness of our CRO model is validated daily as we work globally with pharmaceutical, medical diagnostics, medical technology, and industrial biotechnology companies. Besides commercial applications, supporting basic and translation academic research groups remains our focus and the source of the latest scientific developments for our business development.
It's my personal mission to enable all life science researchers take full advantage of their complex data.
CSO - Matti Nykter
Professor Matti Nykter is our Chief Scientific Officer as well as the head of the Laboratory of Computational Biology at the University of Tampere, Finland. He is a computer scientist who turned early on to bioinformatics allured by the possibilities of applying machine learning and signal processing approaches to biological data. In his academic research he continues to collaborate extensively with top research groups in Finland and the U.S., and was awarded a Finnish Centre of Excellence in Tumor Genetics Research with distinguished oncology research groups at the University of Helsinki. His academic passion is to develop new computational methods to interpret and integrate omics data sets which he wants to disseminate globally to companies and academia through Genevia Technologies. In addition to providing the company with the latest methods and skilled graduates, Matti oversees the level of scientific quality in our R&D and client projects.
CEO - Antti ylipää
Antti founded the company with Professor Matti Nykter in 2011 while working toward his doctoral degree in computational cancer genomics and systems biology. Being a bioinformatician who collaborated extensively with cancer researchers, Antti developed an understanding of how to best help academic researchers use the latest bioinformatics methods to publish high-impact research. Today his passion is to expedite all biological research globally by introducing high-throughput experiments and cutting-edge bioinformatics to academia and industry. Antti spends the best part of his days discussing with our clients in order to help them use bioinformatics for publication and development of their products and services, as well as optimizing our bioinformatics contract research organization (CRO) business model in order to achieve an ever more efficient service.
Partner - Klaus Breitholtz
Our business specialist Klaus keeps the business part of the company running. Klaus holds Master's degrees in both International Business Management and Industrial Engineering, which he admirably combines with an industrious attitude and social aptitude for creating additional value for our clients, perfectly complementing our scientific team. He was head-hunted to our management team early on, making sure that our financial resources are used optimally for the benefit of our own and our clients' scientific teams. As both an industrial engineer and entrepreneurial economist, he enjoys working in a fast-paced, high-tech industry to contribute to the development of agile and innovative business strategies.